OTV

OTV is a venture capital firm that invests in digital health and related technology companies. Founded in 2014 and headquartered in Tel Aviv, with additional offices in New York City and Shanghai, the firm supports entrepreneurs whose products and services aim to improve health outcomes worldwide. OTV focuses on sectors including big data, digital health, mobile, software-as-a-service, and the Internet of Things, seeking scalable platforms with broad impact. The firm leverages its international presence to help portfolio companies access global markets, strategic partnerships, and resources that enable rapid growth. OTV backs visionary founders developing innovative solutions at the intersection of health and technology.

Mayer Gniwisch

General Partner

Amir Lahat

General Partner

Rachely Sitbon

CFO

Manor Zemer

Partner

Past deals in Western Asia

Scopio Labs

Series C in 2022
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.

TytoCare

Series D in 2021
TytoCare develops handheld devices and software that enable users to perform self-examinations, facilitating remote diagnosis by healthcare professionals. The company's tools allow examination of various body areas and diagnose common conditions. TytoCare offers solutions for consumers (TytoHome), professionals (TytoPro), and remote clinics (TytoClinic). Incorporated in 2011, the company is headquartered in Netanya, Israel with an additional office in New York.

Medasense

Series C in 2020
Medasense develops innovative pain monitoring devices that quantify patient response to optimize care and prevent overmedication. Its flagship product, the PMD-200 with NOL® index, uses artificial intelligence and non-invasive sensors to monitor pain objectively in operating rooms and critical care settings. Medasense's solutions are distributed globally, with clinical studies demonstrating improved patient safety and outcomes.

Scopio Labs

Series B in 2020
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.

TytoCare

Venture Round in 2020
TytoCare develops handheld devices and software that enable users to perform self-examinations, facilitating remote diagnosis by healthcare professionals. The company's tools allow examination of various body areas and diagnose common conditions. TytoCare offers solutions for consumers (TytoHome), professionals (TytoPro), and remote clinics (TytoClinic). Incorporated in 2011, the company is headquartered in Netanya, Israel with an additional office in New York.

Harbo Technologies

Series A in 2017
HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills. Based in Tel Aviv, Israel, the company was founded in 2012 and has developed the T-Fence immediate booming system, which features a compact vessel that can produce and deploy an offshore containment boom. This system is designed for rapid deployment by as few as two individuals, making it highly effective in responding to spills from various sources, including large ships, oil rigs, ports, and coastal infrastructure. HARBO's solutions cater to a range of sectors such as marine agriculture, oil spill response, and tourism, enabling organizations to mitigate the environmental and economic impacts of oil spills swiftly and efficiently. The lightweight design of the T-Fence system allows for use in remote locations, requiring minimal logistical support for effective operation.

Gauzy

Series B in 2016
Gauzy develops, manufactures, and supplies innovative glass solutions, specializing in intelligent and switchable glass for modern architecture, vehicles, and design applications. Its products include liquid crystal film technologies, SPD-smart light control films, and PDLC materials, used in various markets worldwide such as construction, automotive, aviation, and consumer electronics. Headquartered in Tel Aviv, Israel, Gauzy has subsidiaries in the US and Germany, with a global presence through dedicated production facilities, R&D centers, sales offices, and distribution networks.

Scopio Labs

Venture Round in 2016
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.

Medasense

Series B in 2016
Medasense develops innovative pain monitoring devices that quantify patient response to optimize care and prevent overmedication. Its flagship product, the PMD-200 with NOL® index, uses artificial intelligence and non-invasive sensors to monitor pain objectively in operating rooms and critical care settings. Medasense's solutions are distributed globally, with clinical studies demonstrating improved patient safety and outcomes.

Harbo Technologies

Seed Round in 2016
HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills. Based in Tel Aviv, Israel, the company was founded in 2012 and has developed the T-Fence immediate booming system, which features a compact vessel that can produce and deploy an offshore containment boom. This system is designed for rapid deployment by as few as two individuals, making it highly effective in responding to spills from various sources, including large ships, oil rigs, ports, and coastal infrastructure. HARBO's solutions cater to a range of sectors such as marine agriculture, oil spill response, and tourism, enabling organizations to mitigate the environmental and economic impacts of oil spills swiftly and efficiently. The lightweight design of the T-Fence system allows for use in remote locations, requiring minimal logistical support for effective operation.

Via Surgical

Series A in 2016
Founded in 2012 by experienced medical device entrepreneurs, Via Surgical specializes in developing innovative surgical fixation technologies. Its flagship product, FasTouch, offers deployable suture fixation for hernia repair, featuring a unique closed-loop suture concept designed to minimize foreign body response and chronic pain.

Scopio Labs

Series A in 2015
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.